The Patent Finder

Andrulis Pharmaceuticals Corp.

Also on record
Records under this name other than patents Andrulis Pharmaceuticals Corp. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 8 of 8 · Back to Andrulis Pharmaceuticals Corp.

PatentTitleStatus Expires Confidence
US 6,140,346Treatment of cancer with thalidomide alone or in combination with other anti-cancer agents
Term ended
Term ended May 4, 2018 · From the USPTO record
Term endedTerm ended May 4, 2018From the USPTO record
US 4,680,308Stable soluble 1,2-diaminocyclohexane platinum complexes
Term ended
Term ended no later than Jul 14, 2007 · Low confidence
Term endedTerm ended no later than Jul 14, 2007Low confidence
US 4,931,553Platinum-polymer complexes and their use as antitumor agents
Term ended
Term ended no later than Jun 5, 2010 · Low confidence
Term endedTerm ended no later than Jun 5, 2010Low confidence
US 5,405,855Treatment of insulin resistant diabetes with thalidomine
Term ended
Term ended no later than Apr 11, 2015 · Low confidence
Term endedTerm ended no later than Apr 11, 2015Low confidence
US 5,434,170Method for treating neurocognitive disorders
Term ended
Term ended no later than Jul 18, 2015 · Low confidence
Term endedTerm ended no later than Jul 18, 2015Low confidence
US 5,643,915Treatment of ischemia/reperfusion injury with thalidomide alone or in combination with other therapies
Term ended
Term ended no later than Jul 1, 2017 · Low confidence
Term endedTerm ended no later than Jul 1, 2017Low confidence
US 5,654,312Treatment of inflammatory and/or autoimmune dermatoses with thalidomide alone or in combination with other agents
Term ended
Term ended no later than Aug 5, 2017 · Low confidence
Term endedTerm ended no later than Aug 5, 2017Low confidence
US 5,731,325Treatment of melanomas with thalidomide alone or in combination with other anti-melanoma agents
Term ended
Term ended no later than Mar 24, 2018 · Low confidence
Term endedTerm ended no later than Mar 24, 2018Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited